Find in Library
Search millions of books, articles, and more
Indexed Open Access Databases
TPD52L1-ROS1 Rearrangement as a New Acquired Resistance Mechanism to Osimertinib That Responds to Crizotinib in Combination With Osimertinib in Lung Adenocarcinoma
oleh: Caihua Xu, MD, Dapeng Li, MD, Weiming Duan, MD, Min Tao, PhD
Format: | Article |
---|---|
Diterbitkan: | Elsevier 2020-06-01 |
Deskripsi
No description available for this item.